+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
All Ages
All Genders
ID03564236

Effectiveness of Nasal High-Flow Therapy for Hospitalized COPD Exacerbations A Randomized Study Comparing Nasal High-Flow plus Standard Care to Standard Care Alone

Led by Marieke Duiverman · Updated on 2024-12-05

136

Participants Needed

3

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Chronic Obstructive Pulmonary Disease COPD is a serious illness that causes high rates of illness and death worldwide. Exacerbations, or flare-ups, of COPD worsen the disease and reduce quality of life. Because current treatments for exacerbations are limited, many patients experience ongoing loss of lung function and frequent hospital stays. This research aims to test nasal high flow therapy nHFT, a newer treatment that delivers warm, humidified air through the nose, to see if it helps recovery during COPD exacerbations. The study is a multicenter, randomized controlled trial involving 136 patients with moderate to severe COPD. Participants will be randomly assigned to receive either standard care or standard care plus nHFT. Standard care includes medications such as oral steroids, antibiotics when needed, inhaled therapies, and oxygen through a low flow system. The nHFT group will receive humidified air at flow rates of 30-50 liters per minute for at least six hours daily during hospitalization and continue using this therapy at home for 90 days after discharge. The study also involves initial phases to optimize nHFT settings and understand how the therapy works. During the study, patients will be monitored for improvements in health-related quality of life over 90 days. Researchers will also assess treatment failure, hospitalizations, frequency of exacerbations, breathing function, heart function, and therapy adherence. Various questionnaires and clinical tests will be used, and costs will be evaluated. The total participation includes hospital stay and 90 days of follow-up, with some outcomes followed up to one year.

CONDITIONS

Brief Title

Nasal High-Flow in COPD

Research Team

M

Marieke L Duiverman, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here